A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Clinical trial NCT05975021 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05975021
- Sponsor
- Windtree Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-07-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.